Pages Menu
TwitterRssFacebook
ISSN (Online): 0975-8232,
ISSN (Print): 2320-5148

International Journal Of
Pharmaceutical Sciences And Research

A Web of Science - ESCI Indexed Journal
Projected Impact Factor (2019): 1.230 , CiteScore (2017): 0.27

Categories Menu

Most Cited

CITATIONS REPORT: (Source- Google Scholar)
Year2010201120122013201420152016201720182019Total
No. of Published Articles2384777606337016536226607007066150
Citations2271423249902871223817931256104562916121486
Article published in 2015 and 2016: 1275, Citation in 2017 to articles Published in 2015 and 2016- 3049
Projected Impact Factor (2017): 3049/1275 = 2.391

Article published in 2016 and 2017: 1282, Citation in 2018 to articles Published in 2016 and 2017- 2104
Projected Impact Factor (2018): 2104/1282 = 1.641

Article published in 2017 and 2018: 1360, Citation in 2019 to articles Published in 2017 and 2018- 1674
Projected Impact Factor (2019): 1674/1360 = 1.230

Total Citations: 21486
 
Title
Views
PDF
Cited
40.

A STUDY COMPARING RESCUE MEDICATIONS: ARFORMOTEROL AND SALBUTAMOL NEBULIZATION IN EXACERBATION OF NON-SEVERE ASTHMA AT A TERTIARY CARE CENTER, NOT NEEDING HOSPITALIZATION

Objectives: Arformoterol is the (R, R) - enantiomer of formoterol, a short and long acting β-2 agonist bronchodilator and is distinguishable from the racemic (R, R/S,S) - diasteriomer of formoterol, which is most commonly used. Some in vitro data show significant bronchodilatation, inhibition of inflammation and marked baseline airway reversibility with arformoterol. Yet, there is a dearth of stu...

Moumita Hazra*, M. Geetha , H.S. Somashekar , B.J. Arun and B. Vidyasagar

Department of Pharmacology , J. J. M. Medical College, Davangere - 577004, Karnataka, India

DOI: http://dx.doi.org/10.13040/IJPSR.0975-8232.4(8).3151-56

3151-3156

2049

709

31.

SOLUBILITY ENHANCEMENT AND DEVELOPMENT OF DISPERSIBLE TABLET OF CANDESARTAN CILEXITIL

Candesartan Cilexitil is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. Candesartan cilexitil is a BCS class II drug having low solubility and high permeability. Candesartan Cilexitil is a prodrug which is rapidly converted to the active drug, Candesartan, by ester hydrolysis during absorption from the gastrointestinal tract. The bioavailability of Candesartan...

A. V. Shrirao and S. Bhilegaonkar *

Department of Pharmaceutics, PES’s Rajaram and Tarabai Bandekar College of Pharmacy, Ponda, Goa, India

DOI: 10.13040/IJPSR.0975-8232.7(10).4164-69

4164-69

2181

678

30.

MAPPING OF NATURAL KAPOSI SARCOMA INHIBITOR USING NETWORK BIOLOGY APPROACH

Identification of protein-ligand interactionnetworks on a proteome scale is crucial to address a wide range of biological problems such as correlating molecular functions to physiological processes and designing safe and efficient therapeutics. In this study we have developed a novel computational strategy to identify ligand binding profiles of proteins across gene families and applied it to predi...

Sadegh Saremy and Jayadeepa R. M.*

Institute of Computational Biology, Bangalore, Karnataka, India

DOI: http://dx.doi.org/10.13040/IJPSR.0975-8232.3(3).853-57

853-857

1626

625